NGF binding to TrkA promotes APP to undergo non-amyloidogenic cleavage, reducing A production [85, 86]
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
The peptide remains usable as long as sterility and storage are correct, but the volume per dose will change
We've also seen vendors photoshop reports or use a single report for all their batches, which completely defeats the purpose
Can you take BPC-157 every day
For further understanding about their safe use and possible perks, check out our articles on peptides for men and peptides to increase testosterone